BSEBoard Meeting5d ago · 6 Aug 2026, 12:37 pm
Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Lincoln Pharmaceuticals ....
Lincoln Pharmaceuticals Ltd · 531633
✦ AI SummaryResults
Lincoln Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
Attachments (1)
📄pdf
Download →
89db39aa-de77-4ae3-8714-52338c20ca14.pdf
View document text
LINCOLN
PHARMACEUTICALS LTD.
HEALTHCARE FOR ALL
Date: August 06, 2026
To, To,
The Manager, Listing Department, The Department of Corporate Service,
National Stock Exchange of India Limited BSE Limited,
(NSE), 1st Floor, New Trading Ring, Rotunda Building,
Exchange Plaza, C – 1, Block – G, Bandra – Kurla Phiroze Jeejeebhoy Tower, Dalal Street,
Complex, Bandra (E), Mumbai-400 051. Mumbai – 400 001.
Scrip Code-LINCOLN Scrip Code-531633
Dear Sir / Madam,
Sub.: Intimation of Board Meeting.
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we
would like to inform that the Meeting of the Board of Directors of the Company is scheduled to be held on
Thursday, 13th August 2026 at the Registered Office of the Company for considering inter-alia the following
matters: -
1) To consider and approve un-audited financial results (Standalone and Consolidated) of the Company for the
quarter ended on June 30, 2026;
2) Any other business with the permission of the Chairman, if any.
Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, trading window has
been closed for trading in securities of the Company from July 01, 2026 and shall reopen after the expiry of 48
hours from the time the result becomes generally available.
Kindly take the same on record.
Thanking you,
Yours faithfully,
For Lincoln Pharmaceuticals Limited
Trusha Shah
Company Secretary & Compliance Officer
Regd. Office: "Lincoln House", Science City Road, Sola, Ahmedabad-380 060. Gujarat, India "i®
Phone, +91-79-4107 8000 I Fax, +91-79-4107 8062 I CIN L24230GJ1995PLC024288
E-mail: info@lincolnpharma.com l Website: www.lincolnpharma.com
Factory: 10, 12, 13. Trimul Estate. Near Khatraj Chokadi, P.O. Khatraj-382721.
Ta.: Kalal, Dist. Gandhinagar, (Guj.) I Phone: +91-79-49135000 I E-mail: khatraj@lincolnpharma.com
.,,.
lntertek '"